LINC01133 promotes the progression of cervical cancer by sponging miR-4784 to up-regulate AHDC1

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7–30. doi:10.3322/caac.21387.
   PubMed Web of Science ®Google Scholar
• Obel J, Souares Y, Hoy D, Baravilala W, Garland SM, Kjaer SK, Roth A. A systematic review of cervical cancer incidence and mortality in the Pacific Region. Asian Pac J Cancer Prev. 2014;15:9433–9437. doi:10.7314/apjcp.2014.15.21.9433.
   PubMedGoogle Scholar
• Shrestha AD, Neupane D, Vedsted P, Kallestrup P. cervical cancer prevalence, incidence and mortality in low and middle income countries: a systematic review. Asian Pac J Cancer Prev. 2018;19:319–324. doi:10.22034/APJCP.2018.19.2.319.
   PubMedGoogle Scholar
• Ellenson LH, Wu TC. Focus on endometrial and cervical cancer. Cancer Cell. 2004;5:533–538. doi:10.1016/j.ccr.2004.05.029.
   PubMed Web of Science ®Google Scholar
• Schmitt M, Dalstein V, Waterboer T, Clavel C, Gissmann L, Pawlita M. Diagnosing cervical cancer and high-grade precursors by HPV16 transcription patterns. Cancer Res. 2010;70:249–256. doi:10.1158/0008-5472.CAN-09-2514.
   PubMed Web of Science ®Google Scholar
• Derks M, van der Velden J, de Kroon CD, Nijman HW, van Lonkhuijzen L, van der Zee AGJ, Zwinderman AH, Kenter GG. Surgical treatment of early-stage cervical cancer: a multi-institution experience in 2124 cases in the Netherlands over a 30-year period. Int J Gynecol Cancer. 2018;28:757–763. doi:10.1097/IGC.0000000000001228.
   PubMed Web of Science ®Google Scholar
• Meijer CJ, Snijders PJ. Cervical cancer in 2013: screening comes of age and treatment progress continues. Nat Rev Clin Oncol. 2014;11:77–78. doi:10.1038/nrclinonc.2013.252.
   PubMed Web of Science ®Google Scholar
• ENCODE Project Consortium, Birney E, Stamatoyannopoulos JA, Dutta A, Guigo R, Gingeras TR, et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature. 2007;447:799–816. doi:10.1038/nature05874.
   PubMed Web of Science ®Google Scholar
• Yang L, Lin C, Jin C, Yang JC, Tanasa B, Li W, Merkurjev D, Ohgi KA, Meng D, Zhang J, et al. lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs. Nature. 2013;500:598–602. doi:10.1038/nature12451.
   PubMed Web of Science ®Google Scholar
• Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M, et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell. 2010;142:409–419. doi:10.1016/j.cell.2010.06.040.
   PubMed Web of Science ®Google Scholar
• Peng Z, Liu C, Wu M. New insights into long noncoding RNAs and their roles in glioma. Mol Cancer. 2018;17:61. doi:10.1186/s12943-018-0812-2.
   PubMed Web of Science ®Google Scholar
• Li J, Hao Y, Mao W, Xue X, Xu P, Liu L, Yuan J, Zhang D, Li N, Chen H, et al. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition. J Hematol Oncol. 2019;12:19. doi:10.1186/s13045-019-0707-8.
   PubMed Web of Science ®Google Scholar
• Wang G, Zhang ZJ, Jian WG, Liu PH, Xue W, Wang TD, Wu C, Zhou Q, Hu W, Wu C, et al. Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/beta-catenin signaling pathway. Mol Cancer. 2019;18:15. doi:10.1186/s12943-019-1010-6.
   PubMed Web of Science ®Google Scholar
• Yu J, Han Z, Sun Z, Wang Y, Zheng M, Song C. LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through beta-catenin-dependent Wnt pathway. J Exp Clin Cancer Res. 2018;37:222. doi:10.1186/s13046-018-0896-y.
   PubMed Web of Science ®Google Scholar
• Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871–890. doi:10.1016/j.cell.2009.11.007.
   PubMed Web of Science ®Google Scholar
• Chaffer CL, San Juan BP, Lim E, Weinberg RA. EMT, cell plasticity and metastasis. Cancer Metastasis Rev. 2016;35:645–654. doi:10.1007/s10555-016-9648-7.
   PubMed Web of Science ®Google Scholar
• Liang H, Yu T, Han Y, Jiang H, Wang C, You T, Zhao X, Shan H, Yang R, Yang L, et al. LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression. Mol Cancer. 2018;17:119. doi:10.1186/s12943-018-0870-5.
   PubMed Web of Science ®Google Scholar
• Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, Tramontano A, Bozzoni I. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell. 2011;147:358–369. doi:10.1016/j.cell.2011.09.028.
   PubMed Web of Science ®Google Scholar
• Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146:353–358. doi:10.1016/j.cell.2011.07.014.
   PubMed Web of Science ®Google Scholar
• Jin X, Chen X, Hu Y, Ying F, Zou R, Lin F, Shi Z, Zhu X, Yan X, Li S, et al. LncRNA-TCONS_00026907 is involved in the progression and prognosis of cervical cancer through inhibiting miR-143-5p. Cancer Med. 2017;6:1409–1423. doi:10.1002/cam4.1084.
   PubMed Web of Science ®Google Scholar
• Luan X, Wang Y. LncRNA XLOC_006390 facilitates cervical cancer tumorigenesis and metastasis as a ceRNA against miR-331-3p and miR-338-3p. J Gynecol Oncol. 2018;29:e95. doi:10.3802/jgo.2018.29.e95.
   PubMed Web of Science ®Google Scholar
• Kong J, Sun W, Li C, Wan L, Wang S, Wu Y, Xu E, Zhang H, Lai M. Long non-coding RNA LINC01133 inhibits epithelial-mesenchymal transition and metastasis in colorectal cancer by interacting with SRSF6. Cancer Lett. 2016;380:476–484. doi:10.1016/j.canlet.2016.07.015.
   PubMed Web of Science ®Google Scholar
• Kong J, Sun W, Zhu W, Liu C, Zhang H, Wang H. Long noncoding RNA LINC01133 inhibits oral squamous cell carcinoma metastasis through a feedback regulation loop with GDF15. J Surg Oncol. 2018;118:1326–1334. doi:10.1002/jso.25278.
   PubMed Web of Science ®Google Scholar
• Zeng HF, Qiu HY, Feng FB. Long Noncoding RNA LINC01133 Functions as an miR-422a Sponge to Aggravate the Tumorigenesis of Human Osteosarcoma. Oncol Res. 2018;26:335–343. doi:10.3727/096504017X14907375885605.
   PubMed Web of Science ®Google Scholar
• Yang XZ, Cheng TT, He QJ, Lei ZY, Chi J, Tang Z, Liao Q-X, Zhang H, Zeng L-S, Cui S-Z. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/beta-catenin pathway. Mol Cancer. 2018;17:126. doi:10.1186/s12943-018-0874-1.
   PubMed Web of Science ®Google Scholar
• Zang C, Nie FQ, Wang Q, Sun M, Li W, He J, Zhang M, Lu K-H. Long non-coding RNA LINC01133 represses KLF2, P21 and E-cadherin transcription through binding with EZH2, LSD1 in non small cell lung cancer. Oncotarget. 2016;7:11696–11707. doi:10.18632/oncotarget.7077.
   PubMedGoogle Scholar
• Zheng YF, Zhang XY, Bu YZ. LINC01133 aggravates the progression of hepatocellular carcinoma by activating the PI3K/AKT pathway. J Cell Biochem. 2019;120:4172–4179. doi:10.1002/jcb.27704.
   PubMed Web of Science ®Google Scholar
• Mao X, Qin X, Li L, Zhou J, Zhou M, Li X, Xu Y, Yuan L, Liu Q-N, Xing H. A 15-long non-coding RNA signature to improve prognosis prediction of cervical squamous cell carcinoma. Gynecol Oncol. 2018;149:181–187. doi:10.1016/j.ygyno.2017.12.011.
   PubMed Web of Science ®Google Scholar
• Dykes IM, Emanueli C. Transcriptional and Post-transcriptional Gene Regulation by Long Non-coding RNA. Genomics Proteomics Bioinf. 2017;15:177–186. doi:10.1016/j.gpb.2016.12.005.
   PubMed Web of Science ®Google Scholar
• Sun W, Yang Y, Xu C, Guo J. Regulatory mechanisms of long noncoding RNAs on gene expression in cancers. Cancer Genet. 2017;216–217:105–110. doi:10.1016/j.cancergen.2017.06.003.
   PubMed Web of Science ®Google Scholar
• Peng L, Yuan X, Jiang B, Tang Z, Li GC. LncRNAs: key players and novel insights into cervical cancer. Tumour Biol. 2016;37:2779–2788. doi:10.1007/s13277-015-4663-9.
   PubMedGoogle Scholar
• Taheri M, Ghafouri-Fard S. Long non-cod-ing RNA signature in cervical cancer. Klin Onkol. 2018;31:403–408. doi:10.14735/amko2018403.
   PubMedGoogle Scholar
• Gao F, Feng J, Yao H, Li Y, Xi J, Yang J. LncRNA SBF2-AS1 promotes the progression of cervical cancer by regulating miR-361-5p/FOXM1 axis. Artificial Cells Nanomedicine Biotechnol. 2019;47:776–782. doi:10.1080/21691401.2019.1577883.
   PubMed Web of Science ®Google Scholar
• Wang M, Ouyang J, Li H. CERNA2: a predictor for clinical progression and poor prognosis in cervical carcinoma. J Cell Biochem. 2019.
   Web of Science ®Google Scholar
• Shan S, Li HF, Yang XY, Guo S, Guo Y, Chu L, Xu M-J, Xin D-M. Higher lncRNA CASC15 expression predicts poor prognosis and associates with tumor growth in cervical cancer. Eur Rev Med Pharmacol Sci. 2019;23:507–512. doi:10.26355/eurrev_201901_16862.
   PubMed Web of Science ®Google Scholar
• Liu J, Yu Q, Ye Y, Yan Y, Chen X. Abnormal expression of miR-4784 in chondrocytes of osteoarthritis and associations with chondrocyte hyperplasia. Exp Ther Med. 2018;16:4690–4694. doi:10.3892/etm.2018.6739.
   PubMed Web of Science ®Google Scholar